Hakim-Moulay Dehbi obtained his PhD in biostatistics from Imperial College London in 2017. Currently Hakim is Head of Statistics of the Comprehensive Clinical Trials Unit at UCL. His methodological research interests include the design of early-phase trials, including dose-finding trials as well as early-phase randomised designs. Dr Dehbi has more than 30 publications in prestigious medical journals, including the NEJM, the Lancet, and Statistics in Medicine. From an applied perspective, Hakim has mostly worked as statistician on cardiovascular and oncology trials.